CD81 costimulation skews CAR transduction toward naive T cells
Open Access
- 28 January 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (5)
Abstract
Significance: Chimeric antigen receptors (CARs) are engineered, artificial T cell receptors that can redirect cytotoxic immune T cells to eliminate cancer. Previous reports describe the benefit of less differentiated naive T cell subtypes for the purpose of CAR therapy. Here we test CD81, a T cell costimulator that preferentially activates naive T cells, for CAR engineering. We show that CD81 costimulation of naive T cells prior to CAR transduction can lead to enhanced CAR expression in this T cell subset.Keywords
Funding Information
- St. Baldrick''''s Foundation (329620)
This publication has 45 references indexed in Scilit:
- The Stoichiometric Production of IL-2 and IFN-γ mRNA Defines Memory T Cells That Can Self-Renew After Adoptive Transfer in HumansScience Translational Medicine, 2012
- Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81Proceedings of the National Academy of Sciences, 2012
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in MiceClinical Cancer Research, 2011
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced LeukemiaScience Translational Medicine, 2011
- Genetic Engineering of Murine CD8+ and CD4+ T Cells for Preclinical Adoptive Immunotherapy StudiesJournal of Immunotherapy, 2011
- Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyBlood, 2011
- Adoptively transferred effector cells derived from naïve rather than central memory CD8+T cells mediate superior antitumor immunityProceedings of the National Academy of Sciences, 2009
- Efficient Human Hematopoietic Cell Transduction Using RD114- and GALV-Pseudotyped Retroviral Vectors Produced in Suspension and Serum-Free MediaHuman Gene Therapy, 2009
- Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia XenograftsClinical Cancer Research, 2007